Synthesis and biological evaluation of glaucocalyxin A derivatives as potential anticancer agents

European Journal of Medicinal Chemistry
2014.0

Abstract

A series of Mannich base type derivatives of Glaucocalyxin A (GLA) were designed and prepared. The cytotoxicity of these compounds was evaluated against six tumor cell lines (SMMC-7721, B16, SGC-7901, A549, KB, HL-60). Most compounds exhibited potent antiproliferative effects with low micromolar IC50 values. Compound 1 with para methyl benzyl amine moiety and compound 16 with cyclohexylamine moiety displayed the highest inhibition efficacy. Significantly, the cytotoxicity of compound 1 was much lower than GLA against the normal human liver cell (HL-7702). The in vitro stability assay revealed that transformation of GLA to Mannich base type derivatives improved the compound stability in rat plasma. Finally, decomposition product analysis supported that compound 1 could act as a prodrug and release GLA in the intracellular environment.

Knowledge Graph

Similar Paper

Synthesis and biological evaluation of glaucocalyxin A derivatives as potential anticancer agents
European Journal of Medicinal Chemistry 2014.0
Synthesis and biological evaluation of novel spin labeled 18β-glycyrrhetinic acid derivatives
Bioorganic & Medicinal Chemistry Letters 2012.0
Synthesis and biological evaluation of novel 8-aminomethylated oroxylin A analogues as α-glucosidase inhibitors
Bioorganic & Medicinal Chemistry Letters 2008.0
Structure−Activity Relationship Analysis of Novel Derivatives of Narciclasine (an Amaryllidaceae Isocarbostyril Derivative) as Potential Anticancer Agents
Journal of Medicinal Chemistry 2009.0
Anticancer evaluation of some newly synthesized N-nicotinonitrile derivative
European Journal of Medicinal Chemistry 2013.0
Synthesis, antiproliferative activity in cancer cells and theoretical studies of novel 6α,7β-dihydroxyvouacapan-17β-oic acid Mannich base derivatives
Bioorganic & Medicinal Chemistry 2010.0
Design, synthesis and biological evaluation of matrine derivatives as potential anticancer agents
Bioorganic & Medicinal Chemistry Letters 2018.0
N-(2-{3-[3,5-Bis(trifluoromethyl)phenyl]ureido}ethyl)-glycyrrhetinamide (<b>6b</b>): A Novel Anticancer Glycyrrhetinic Acid Derivative that Targets the Proteasome and Displays Anti-Kinase Activity
Journal of Medicinal Chemistry 2011.0
In search of a cytostatic agent derived from the alkaloid lycorine: Synthesis and growth inhibitory properties of lycorine derivatives
Bioorganic &amp; Medicinal Chemistry 2011.0
Design, synthesis and biological evaluation of novel 1-hydroxyl-3-aminoalkoxy xanthone derivatives as potent anticancer agents
European Journal of Medicinal Chemistry 2014.0